Olema Oncology, Inc
Price
FilingsNewest: Form 8-K, charter or bylaws changeNov 12 →InsidersNo open-market buys. 6 insiders sold $24.7M, 0 of 25 sales on a 10b5-1 plan.→HoldersFMR 13.9%Paradigm Biocapital 9.9%Jupiter Topco 8.1%→Financing →PeersClosest companies: ORIC, MREO, VRDN→
From the filings
Figures
- Net income
- −$235.9Mlast 12 months
- Operating cash flow
- −$164.7Mlast 12 months
- Cash and equivalents
- $47.5Mat the last balance sheet
- Shares outstanding
- 87.5M shareson issue
Filings, newest first
- Nov 128-KCharter or bylaws change
- Nov 1010-QQuarterly report
- Nov 108-KResults of operations
- Oct 158-KDirector or officer change
- Aug 138-KDirector or officer change
- Aug 1010-QQuarterly report
- Aug 108-KResults of operations
- Jun 238-KShareholder vote
- Mar 1610-KAnnual report
- Mar 54Insider trade
- Jan 214Insider trade